Cizzle Biotechnology Q&A: MoU is a very, very significant development for the business (LON:CIZ) 29 June 2021
ICG Enterprise Trust Analyst Q&A “£201m of resources to take strong pipeline opportunities” (LON:ICGT) 15 June 2021
Cerillion Q&A: Channel partners increase global sales reach and delivery of capability & capacity (LON:CER) 11 June 2021
MySale Group plc Shares off 40% since solid July pre-close trading update creates opportunity 28 August 2018
Epwin Group plc Trading in line in FY18 despite the market outlook remaining difficult 22 August 2018
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
LondonMetric Property sells non-core assets for £57.9m, acquires Basildon retail park 18 November 2024
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Cizzle Biotechnology Q&A: MoU is a very, very significant development for the business (LON:CIZ) 29 June 2021
ICG Enterprise Trust Analyst Q&A “£201m of resources to take strong pipeline opportunities” (LON:ICGT) 15 June 2021
Cerillion Q&A: Channel partners increase global sales reach and delivery of capability & capacity (LON:CER) 11 June 2021
MySale Group plc Shares off 40% since solid July pre-close trading update creates opportunity 28 August 2018
Epwin Group plc Trading in line in FY18 despite the market outlook remaining difficult 22 August 2018
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
LondonMetric Property sells non-core assets for £57.9m, acquires Basildon retail park 18 November 2024
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 12.94% Upside Potential 15 December 2025
United Therapeutics Corporation (UTHR) Stock Analysis: Navigating Potential with a 4.91% Upside 15 December 2025
DaVita Inc. (DVA) Stock Analysis: Insights into a 19% Potential Upside for Healthcare Investors 15 December 2025
Henry Schein, Inc. (HSIC) Investor Outlook: Navigating Growth Opportunities in Healthcare Distribution 15 December 2025
HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a $113 Billion Healthcare Giant with Strategic Growth 15 December 2025
Chemed Corp (CHE) Stock Analysis: A 33.53% Potential Upside Amidst Strong Analyst Support 15 December 2025
Tempus AI, Inc. (TEM) Stock Analysis: Evaluating the 29.47% Potential Upside for Investors 15 December 2025
Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking the 21.31% Potential Upside for Investors 15 December 2025
Option Care Health (OPCH) Stock Analysis: A Promising 9.67% Upside for Investors in the Healthcare Sector 15 December 2025
Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a Healthcare Giant with a 9.29% Potential Upside 15 December 2025
Viatris Inc. (VTRS) Stock Analysis: Navigating a 6.82% Potential Upside in the Healthcare Market 15 December 2025
Repligen Corporation (RGEN) Investor Outlook: Analyzing a 19.7% Potential Upside in the Bioprocessing Sector 15 December 2025
Sanofi (SNY) Stock Analysis: Attractive 23.52% Upside Potential Amid Strong Analyst Support 15 December 2025
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating Growth in Sleep Apnea Solutions 15 December 2025
Gilead Sciences (GILD) Stock Analysis: A Closer Look at a 9.63% Potential Upside in the Biopharma Giant 15 December 2025
Merit Medical Systems (MMSI) Stock Analysis: Exploring an 18% Upside Potential in the Healthcare Sector 15 December 2025
McKesson Corporation (MCK) Stock Analysis: Unlocking a 15% Upside Potential in the Healthcare Sector 15 December 2025
Genmab A/S (GMAB) Stock Analysis: A Biotechnology Powerhouse with 20.77% Upside Potential 15 December 2025
Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing 3 July 2024
Cizzle Biotechnology Q&A: MoU is a very, very significant development for the business (LON:CIZ) 29 June 2021
ICG Enterprise Trust Analyst Q&A “£201m of resources to take strong pipeline opportunities” (LON:ICGT) 15 June 2021
Cerillion Q&A: Channel partners increase global sales reach and delivery of capability & capacity (LON:CER) 11 June 2021
MySale Group plc Shares off 40% since solid July pre-close trading update creates opportunity 28 August 2018
Epwin Group plc Trading in line in FY18 despite the market outlook remaining difficult 22 August 2018
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
